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ABSTRACT
The early development of many animals relies on the
posttranscriptional regulations of maternally stored
mRNAs. In particular, the translation of maternal
mRNAs is tightly controlled during oocyte matura-
tion and early mitotic cycles in Xenopus. The
Embryonic Deadenylation ElemeNt (EDEN) and its
associated protein EDEN-BP are known to trigger
deadenylation and translational silencing to several
mRNAs bearing an EDEN. This Xenopus RNA-
binding protein is an ortholog of the human protein
CUG-BP1/CELF1. Five mRNAs, encoding cell cycle
regulators and a protein involved in the notch
pathway, have been identified as being deadeny-
lated by EDEN/EDEN-BP. To identify new EDEN-BP
targets, we immunoprecipitated EDEN-BP/mRNA
complexes from Xenopus tropicalis egg extracts.
We identified 153 mRNAs as new binding targets for
EDEN-BP using microarrays. Sequence analyses of
the 3’ untranslated regions of the newly identified
EDEN-BP targets reveal an enrichment in putative
EDEN sequences. EDEN-BP binding to a subset of
the targets was confirmed both in vitro and in vivo.
Among the newly identified targets, Cdk1, a
key player of oocyte maturation and cell cycle
progression, is specifically targeted by its 3’ UTR
for an EDEN-BP-dependent deadenylation after
fertilization.
INTRODUCTION
The posttranscriptional regulation of gene expression
relies on speciﬁc interactions between mRNAs and trans-
acting factors that could be either proteins or microRNA.
Known binding sites for regulatory RNA-binding proteins
(RNA-BPs) are usually short and degenerated sequences
those provide insuﬃcient information to allow a systema-
tic bioinformatics screen to identify the target mRNAs.
However, the deﬁnition of the RNA targets of a given
RNA-BP is crucial for the global understanding of the
posttranscriptional processes in which the protein is
involved. In amphibians, oocyte growth enables a single
cell to contain the information required for the ﬁrst 12
mitotic cycles and it is even suﬃcient to allow partheno-
genetic development if centrosomes are provided (1).
Notably, after an initial accumulation of the so-called
maternal mRNAs in the growing oocyte, transcription
ceases and the oocyte is blocked in prophase of the ﬁrst
meiotic division (stage VI oocyte). In Xenopus, upon
hormonal treatment, meiosis resumes and a matured
oocyte blocked in metaphase of the second meiotic
division is laid that can be fertilized to allow zygotic
mitosis. Transcription only resumes after the 12th cell
cycle. This emphasizes the requirement for posttranscrip-
tional regulation in the period from a stage VI oocyte to
the 12th cell cycle.
From the hormonal activation of stage VI oocytes to
the onset of transcription in the 4000 cell embryo,
a cascade of translational regulatory mechanisms takes
place that allows meiosis and early zygotic mitosis to
occur in a coordinated manner [for a review see (2)].
Posttranscriptional mechanisms involve both global
translational inhibition mechanisms as well as mechanisms
targeting speciﬁc mRNAs for translation or translational
silencing at speciﬁc time during oogenesis or development.
Among the mechanisms involved, the deadenylation
targeted by the Embryonic Deadenylation ElemeNt
Binding Protein (EDEN-BP) ensures the silencing of
c-Mos and Aurora A translation after fertilization by
binding to the EDEN motif in their 30 UTR (3,4).
In addition to its role in very early development,
EDEN-BP is required for the metamerization of the
somites (5) by regulating the accumulation of Xenopus
suppressor of hairless mRNA. CUG-BP1/CELF1, the
mammalian ortholog of EDEN-BP can regulate both
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alternative splicing and translation (6). Recently, analysis
of CUG-BP1/CELF1/ mice indicated that CUG-BP1/
CELF1 is globally required for the viability of the animals
and, more speciﬁcally for spermatogenesis (7). However,
no known CUG-BP1/CELF1 or EDEN-BP target can
explain these observed phenotypes.
So far the various analyses of potential substrates for
the EDEN/EDEN-BP-dependent deadenylation pathway
have identiﬁed ﬁve mRNAs as EDEN-BP target: Aurora
A/(Eg2), c-Mos, the kinesin-like Eg5, Cdk2/(Eg1) and
Xsu(H); (3,5,8,9) the former four having been selected on
their deadenylation behavior and the latter by its ability to
bind EDEN-BP in UV-induced crosslinking experiments.
The proteins encoded by three of these mRNAs (Aurora
A, c-Mos and Cdk2) are known cell cycle regulators
(10–12). Recently, an in vitro analysis of artiﬁcial CUG-
BP1/CELF1 RNA ligand was performed and indicated
that CUG-BP1/CELF1 binding sites could be represented
as the occurrence of ﬁve UGU trinucleotides in a 35 nt
window. However, such a motif is commonly represented
in the genome and is of little predictive value. In the
present work we used a combination of RNA–protein
complex immunopuriﬁcation (IP) and hybridization of
copuriﬁed mRNA onto microarrays, to identify new
EDEN-BP targets solely on the base of EDEN-BP
binding.
To our knowledge this is the ﬁrst identiﬁcation on a
large scale of mRNA targets of a RNA-BP involved in the
early Xenopus development. Among the 158 EDEN-BP
targeted mRNAs, we identiﬁed an overrepresented cluster
of unfertilized egg (UFE) maternal mRNAs involved in
the meiotic process of oocyte maturation. As EDEN-BP
activity is turned on at, or just after, fertilization (13),
the presence of this cluster suggests that EDEN-BP may
be part of a mechanistic switch from ‘meiosis to mitosis’ or
from ‘oogenesis to early development’.
MATERIALS AND METHODS
Microarray design
A set of 3000 50mer oligonucleotides was designed from
2898 Xenopus tropicalis gene sequences and spotted in
duplicate (14). Oligonucleotides were spotted in 16 blocks
of 14 14 spots, each containing an Arabidopsis thaliana
probe, as well as blank and empty buﬀer controls. MWG
Biotech performed oligonucleotide design, synthesis and
spotting. X. tropicalis gene sequences were derived from
the assembly of public and in-house ESTs (15).
Description of the array has been deposited at
ArrayExpress (http://www.ebi.ac.uk/arrayexpress/).
UFE collection and extract
To prepare UFE extracts, eggs were collected from two
X. tropicalis females after an injection with 100U of
human chorionic gonadotropin. Extracts were prepared as
described for Xenopus laevis (16). Brieﬂy, collected eggs
were washed in F1 buﬀer (N-2-hydroxyethylpiperazine-
N-2-ethanesulfonic acid 10mM pH 7.6, NaCl 31.25mM,
KCl 1.75mM, CaCl2 1mM and MgCl2 60mM), dejellied
in 2% cysteine pH 7.8 in F1, washed with F1 and sorted.
Eggs were then washed with XB (N-2-hydroxyethylpiper-
azine-N-2-ethanesulfonic acid 10mM pH 7.7, KCl
100mM, MgCl2 1mM, CaCl2 0.1mM and sucrose
50mM) and placed in a 1.5ml microtube. Buﬀer was
replaced by XB buﬀer containing 10 mg/ml chymostatine,
10 mg/ml leupeptine and 100mg/ml cytochalasine B and
eggs were lightly swirled in this buﬀer. Eggs were packed
(500 g, 1min, 208C) to remove interstitial buﬀer and
layered by 200 ml of versilube oil (F-50, General Electric).
Eggs were packed again (500 g, 1min, 208C) then
centrifuged at high speed (10 000 g, 10min, 48C). The
cytoplasmic fraction was collected and protease inhibitor
(as above) and RNAsin (100U/ml) were added. The
cytoplasmic extract was centrifuged (10 000 g, 10min, 48C)
and the supernatant was stored at 808C. When embryos
were used, fertilization was performed according to
standard procedures (17).
EDEN-BP IP
Two polyclonal antibodies detecting EDEN-BP (aE1 or
aE2) were puriﬁed on the same recombinant protein as
that used to immunize rabbits (3). For IP, protein
A-puriﬁed IgG from an unrelated serum and aE1 or
aE2 were covalently bound to protein A/Dynabeads
(Dynal). Thirty microliter of antibodies-coupled beads
were then incubated (1 h, 208C) in 50 ml UFE extracts
diluted 5-fold in XB buﬀer to a total volume of 250ml in
presence of RNAsin (0.2U/ml) (Promega). After binding
and extensive washes with PBS 1X (6 800 ml), bound
protein complexes were eluted by boiling (5min) in 60mM
Tris pH 6.8, 1% SDS, 10% glycerol and 0.01%
bromophenol blue. An aliquot was saved for western
blot analysis while RNA extraction was performed on the
eluates with Tri-reagent following the manufacturer
recommendations (MRC).
RNA labeling
RNAs (250 ng) were reverse transcribed into double-
stranded cDNAs by MMLV-RT using an oligodT-T7
promoter primer at 408C. Labeled cRNAs were tran-
scribed from the cDNAs by T7 RNA polymerase with
direct incorporation of Cy5-CTP or Cy3-CTP, using
the Low Input Fluorescent Linear Ampliﬁcation Kit
(Agilent). Probes were puriﬁed using the RNAeasy kit
(Qiagen). Label incorporation and probe yield was
controlled on a Nanodrop-1000.
Probing of cDNAmicroarrays
QMT Epoxy Slides were blocked 15min at 508C,
in 50mM ethanolamine and 0.1% SDS in 0.1M Tris,
pH 9.0. Fluorescent probes (700 ng each of tested and
reference cRNAs) were mixed with Hybridization Buﬀer
(MWG). The mix was denatured 3min at 958C and
applied to the microarray. Hybridizations were performed
at 428C overnight and followed by a 15min wash in 2X
SSC with 0.2% SDS at 308C, then two 15min washes in
1X SSC at 308C and two 15min washes in 0.5X SSC at
208C. Microarrays were scanned using a GenePix 4000B
scanner (Axon Instruments) and GenepixPro was used to
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acquire spot information. GPR ﬁles have been deposited
at ArrayExpress (http://www.ebi.ac.uk/arrayexpress/).
Microarray analysis
Two separate IPs were performed with two female frogs
using the two diﬀerent antiEDEN-BP sera (aE1, aE2) and
controlled by an IP with rabbit IgG. For each IP
experiment, the labeled RNAs were hybridized on two
slides, each slide bearing two sets of oligonucleotides.
Therefore, for the IP with each antibody, four experi-
mental values were obtained. In the ﬁrst experiment,
the eluted RNA were labeled with CTP-Cy5 while the
reference sample composed of UFE total RNA was
labeled with CTP-Cy3. In the second experiment, the
eluted RNAs were labeled with CTP-Cy3 and the
reference sample with CTP-Cy5.
In each experiment, data obtained from microarray
scanning were submitted to Signiﬁcance Analysis of
Microarray (SAM) (18) using the TMEV 4 suite (http://
www.tm4.org/mev.html) in order to determine the
mRNAs speciﬁcally enriched in EDEN-BP IP compared
to the IgG IP or input samples. In a second step the set
of genes speciﬁcally enriched in IP 1 (n=307, d=0.588,
minimal fold change=1.81 and false discovery rate=
0%) was compared with the set of genes speciﬁcally
enriched in IP 2 (n=336, d=1.1962, minimal fold
change=1.86 and false discovery rate=0%) to deter-
mine the mRNAs which are enriched in all the IP we
performed. All the relative data have been deposited at
ArrayExpress (http://www.ebi.ac.uk/arrayexpress/).
Databases and sequences analysis
Taking advantage of the availability of X. tropicalis
genomic sequences and partial genome annotations, we
recovered 27 916 predicted transcripts (transcript_xt) and
predicted proteins from the last X. tropicalis genome
release (Version 4.1, August 2005). We could unambigu-
ously match 1954 JGI predicted transcripts to at least one
of our 3000 oligos. By comparing the predicted ORF and
transcripts we extracted 7474 30 UTR (UTR_xt); 1236 of
the transcripts represented on the microarray contained
identiﬁed 30 UTR (UTR_array). The 158 EDEN-BP target
mRNA identiﬁed in our work are represented by 108
predicted transcripts and 95 30 UTRs (UTR_target). Two
control dataset were derived from the UTR_target
dataset. UTR_Target_Rev is the reverse complement
of the UTR_target dataset (revseq, EMBOSS suite), this
dataset does not retain the nucleotide composition. The
UTR_Target_Shuﬄe dataset is derived from UTR_Target
by shuﬄing (shuﬄeseq, EMBOSS suite) the sequences
retain the nucleotide composition of each sequence.
Datasets (Utr_array, UTR_Target, UTR_Target_Rev
and UTR_target_Shuﬄe) are available in Supplementary
Data S1.
To deﬁne a bonaﬁde EDEN motif, we recovered from
(19) the sequences selected for binding in vitro to CUG-
BP-1, and identiﬁed as family 1. This set of 63 sequences
was used to perform a motif search using MEME (http://
meme.sdsc.edu/meme/meme.html). A motif of 15 nt
(EDEN15) was determined to be present in 39 out of 62
sequences (P< 103). This motif was represented as a
simple frequency matrix and a sequence logo was
generated (20,21). The simple frequency matrix was used
with PROFIT (http://emboss.bioinformatics.nl/cgi-bin/
emboss) to identify and count transcripts in datasets
bearing the deﬁned EDEN15 motif (Supplementary Data
S2, EDEN15). For each match, a score was attributed to
the identiﬁed motif as a percentage of the best possible
match. As a control, a motif was generated by randomly
permutating nucleotide positions in the EDEN15 motif
and ensuring there was no UGU trinucleotide present
in the resulting motif; this motif retains the overall
nucleotide composition of the EDEN15 motif
(Supplementary Data S2, NO_UGU).
RT-PCR and transcription template synthesis
To control the IP of EDEN-BP mRNA targets, the RNA
extracted from the IPs was primed with oligo-dT primer
and reverse transcribed with Superscript II reverse
transcriptase following the manufacturer recommendation
(Invitrogen). PCR were performed in standard conditions
with the primers presented in Supplementary Data S3.
Except for 30 Eg5 and 30 Eg5C6 (3), transcription
templates for the RNAs to be tested in electrophoretic
mobility shift assay (EMSA) and UV-crosslinking experi-
ments were generated by PCR. A forward primer
corresponding to a T7 promoter followed by the speciﬁc
sequences was synthesized (for sequences see
Supplementary Data S3). PCR products were puriﬁed
and conﬁrmed by sequencing from the T7 primer. The
transcription templates were subsequently used to synthe-
size radiolabeled RNA using T7 RNA polymerase
(Promega), NTPs and a-[32P]UTP (NEN). Each radiola-
beled probe was <200-nt long. For microinjection into
embryos, in vitro transcription was realized as previously
described (17) in presence of cap analog (Promega).
3’UTR cloning
pgemGbORFV5 was constructed by inserting the PCR-
ampliﬁed GbORFV5 (PCR template pGbORF (17),
oligonucleotides T7 and ORFV5-R, for oligonucleotide
sequences see Supplementary Data S3) into the pgemT
easy vector (Promega). pGbORF-AurA was constructed
by inserting the GBORFV5 [digested KpnI/SphI (blunt)
from pgemGbORFV5] into the vector Gb-Eg2-410-A65
(22) digested KpnI/PstI (blunt). pGbORF-Cdk1 was
constructed by inserting the RT-PCR-ampliﬁed Cdk1 30
UTR (for oligonucleotide sequences see Supplementary
Data S3) into the NotI (blunt)/BamHI sites of vector
pGbORFV5-AurA, therefore, replacing the partial AurA
30 UTR sequence by the complete Cdk1 30 UTR.
All constructions were controlled by sequencing.
Transcription templates were generated by linearizing
the pGbORFV5-AurA or pGbORFV5-Cdk1 with EcoRV
to allow synthesis of a RNA bearing a 65 nt poly(A)tail as
described previously (17).
Recombinant EDEN-BP synthesis and EMSA
His-tagged EDEN-BP was produced in bacteria
and puriﬁed on Ni-NTA agarose beads (Qiagen) as
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described (23). Denaturing electrophoresis and Coomassie
blue staining was used to check the purity of recombi-
nant EDEN-BP and to measure its concentration.
EMSA were performed as described (23). Dried gels
were submitted to Phosphoimager (STORM 840,
Molecular Dynamics) analysis. Quantiﬁcations were
made using the ImageQuant software (Version 5.4,
Molecular Dynamics). The apparent Kd was measured as
the concentration of recombinant EDEN-BP required for
a ratio of bound to free probe of 1.
Crosslinking experiments
About 100 fmol of radiolabeled RNA were incubated in
10-fold diluted UFE extracts for 30min at 238C. Extracts
were UV irradiated as described (9). RNAse A was added
to the extract (ﬁnal concentration 2 mg/ml) and incubated
1 h at 378C. SDS–PAGE loading buﬀer was added
and proteins were separated by SDS–PAGE on a
10% acrylamide gel. Dried gels were submitted to
Phosphoimager. When indicated, speciﬁc (30 Eg5) or
non-speciﬁc (30 Eg5C6) cold competitor RNA was added
to the initial incubation step. 30 Eg5 contain 40 nt of Eg5
30 UTR centered on the EDEN motif while 30 Eg5C6 is
identical to 30 Eg5 except in the substitution of a (UG)3
motif by (C)6 in the EDEN motif [described in (3)].
RESULTS
EDEN-BP IP selectively enriched known EDEN-BP target
mRNAs
To identify mRNAs bound in vivo to EDEN-BP, we
performed IPs from UFE extracts with two diﬀerent
antibodies (aE1 and aE2) raised against recombinant X.
laevis EDEN-BP (3). The antibodies were puriﬁed on
recombinant EDEN-BP protein. Western blot analysis of
crude UFE extract (Figure 1A) showed that both serum
recognized EDEN-BP as a speciﬁc band located
at 50 kDa (arrowhead) but diﬀered in cross-reacting
background signals. A western blot analysis of a typical
experiment is presented (Figure 1B) where, EDEN-BP
in the immunopuriﬁed RNPs was revealed using
an antiEDEN-BP antibody raised in guinea pig (3).
EDEN-BP was selectively puriﬁed with aE1 or aE2 and
could be detected as multiple bands representative of the
various phosphorylation states of the protein (13). No
EDEN-BP could be detected in the control IgG puriﬁca-
tion. As can be observed in the input lane, the guinea pig
antibody recognized, in addition to EDEN-BP, two bands
at 80 and 110 kDa that were not present in the
immunopuriﬁed fractions showing the speciﬁcity of the
IP procedure. To verify that known EDEN-BP targets
were enriched in the EDEN-BP fractions, total RNA was
extracted from the eluted IgG, aE1 and aE2 fractions
shown in Figure 1B and used in RT-PCR analysis.
As shown in Figure 1C, the Vg1 mRNA is detectable in
the UFE extract but not detectable in either IgG, aE1 or
aE2 eluted samples. In contrast, Aurora A(Eg2), Eg5 and
c-Mos mRNAs were all signiﬁcantly enriched in the aE1
and aE2 samples while not or barely present in the IgG
sample. These RNA samples were used to identify new
EDEN-BP target mRNAs on microarrays.
Microarray identification of mRNAs bound to EDEN-BP
RNAs were extracted from the eluted fractions and from
the input egg extracts. In the two experiments reported
here, the UFE extracts were obtained from diﬀerent
X. tropicalis females. In one experimental set (aE1, aE2
and IgG, input from female 1 presented in Figure 1)
RNAs were labeled with CTP-Cy5 while a reference
sample composed of total RNA from a stock of UFEs
was labeled with CTP-Cy3 (see Materiels and Methods
section). A dye swap was performed for the second
experiment (second female). For each sample, hybridiza-
tion was performed in duplicate. Data were analyzed
by SAM algorithm (18) to detect mRNAs selectively
enriched in each IP experiments compared with the
control IgG experiment. SAM for experiment 1 identiﬁed
307 mRNAs speciﬁcally overrepresented in the
antiEDEN-BP eluates. SAM for experiment 2 identiﬁed
336 mRNAs speciﬁcally overrepresented in the
antiEDEN-BP eluates. Comparing the two dye swap
experiments, 162 oligo hits corresponding to 158 diﬀerent
mRNAs were found to be selectively associated with the
endogenous EDEN-BP in all four IP experiments
(Supplementary Data S4 for the SAM scores and S5 for
the annotations of the oligonucleotides). Our positive
controls, the ﬁve known EDEN-BP targets mRNAs
[Cdk2(Eg1), Eg5, Aurora A, Xsu(H) and c-Mos] are
among the 158 identiﬁed target. Furthermore, it was
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Figure 1. EDEN-BP antibodies and IP speciﬁcities. (A) aE1- and aE2-
puriﬁed polyclonal antibodies were used to detect endogenous EDEN-
BP in crude UFE extracts. Protein size (kiloDalton) are indicated on
the left side of the panel. The arrowhead indicates EDEN-BP.
(B) Western blot analysis of EDEN-BP/RNA complexes immuno-
puriﬁed from UFE extract with control IgG, aE1 or aE2 antibodies as
indicated. Input indicates initial sample (1/7.5). Detection is realized
with a guinea pig antibody raised against recombinant EDEN-BP.
(C) Detection by RT-PCR of the mRNA recovered from the IP eluates
presented in B. The tested mRNAs are indicated on the right of the
panel. Input is the original UFE extract and RT corresponds to
control reaction with input RNA and no reverse transcriptase.
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recently shown that the highly conserved 30 UTR of
LMO4 [a protein involved in modulation of BMP
signaling (24)] was bound by CUG-BP1. LMO4 is
uncovered in our screen as one of the new target.
Therefore, our analysis identiﬁed 153 new EDEN-BP
targets. It is noteworthy that the same analysis realized by
comparing aE1 and aE2 to total input RNA gave similar
results.
The EDENmotif is overrepresented in the
coimmunopurified mRNAs
Because it is expected that the identiﬁed target mRNAs
contained EDEN motifs, we used all annotated transcripts
and 30 UTR from the JGI V4.1 assembly to search for the
presence of an EDEN motif. Recently, SELEX experi-
ments to identify in vitro RNA targets for CUG-BP1/
CELF1 have been performed (19). Using the MEME
algorithm (http://meme.sdsc.edu/meme/meme.html) we
identiﬁed a motif of 15 nt (EDEN15) as being statistically
enriched in this SELEX dataset. This EDEN15 motif
was present in 32 out of 63 sequences (P< 0.001). This
motif was represented as a simple frequency matrix
(Supplementary Data S2, EDEN15) and a sequence logo
(Figure 2A). This motif is present in the original targets
Aurora A, c-Mos, Eg5, Xsu(H) and Cdk2 with a score of
70, 86, 76, 82 and 83%, respectively, of its best match.
Because the three RNA recognition motif (RRM) for
the three EDEN-BP orthologs (mm, hs and xt) are highly
conserved (almost 100%) and because the human
ortholog can functionally and speciﬁcally replace the
Xenopus protein in egg extract (25) we used the EDEN15
motif deﬁnition to count the number of sequence
harboring putative EDEN motif.
When comparing the percentage of 30 UTR sequences
harboring an EDEN15 motif above a given score
(Figure 2B), the EDEN15 motif was clearly overrepre-
sented in the 30 UTR sequences of the identiﬁed target
RNA (UTR_Target, n=95) when compared to the 30
UTR of all the RNA represented on the microarray
(Utr_array, n=1236). To ensure the relevance of
the EDEN15 motif, we searched for EDEN15 motif
in the UTR_target dataset after shuﬄing it
(UTR_Target_shuﬄe) or using the reverse complement
strands (UTR_Target_Rev). We found that no over-
representation of EDEN15 motif was detected in these
datasets when compared with Utr_array. These analyses
showed that the EDEN15 motif is clearly overrepresented
in the 30 UTR of the target mRNAs identiﬁed with 90%
of the 30 UTR harboring an EDEN15 motif with a score
above 70%.
As an additional control, we generated a random
15 nt motif with the same base composition as the
EDEN15 motif but devoid of any UGU in its consensus.
When this motif is searched for in the databases
(Supplementary Data S2, NO_UGU motif), only a very
limited enrichment was observed between the UTR target
and the control dataset. Therefore, the EDEN15 motif is
clearly representative of putative binding sites for EDEN-
BP and the UGU trinucleotide, a key pattern of this
element as can be observed on the sequence logo
(Figure 2A).
The intersection between experiments 1 and 2 consists
of 158 diﬀerent mRNAs. These mRNAs were, therefore,
isolated with both antiserum and in both experiments and
are enriched in the EDEN15 motif. To determine whether
the RNA that was puriﬁed in only one experiment contain
putative EDEN, we searched in the 30 UTR of these
transcripts for the EDEN15 motif. No speciﬁc EDEN15
motif enrichment could be observed in these two 30 UTR
populations when compared with the control dataset
(Supplementary Data S6). This indicates that the popula-
tion of RNA puriﬁed during one experiment certainly
consists of a population directly bound to the EDEN-BP
protein and another population probably representative of
background signals. This justiﬁes the need to corroborate
the results using several serum and repetitions of the IP
experiments. Next, we postulated that mRNA speciﬁcally
immunoprecipitated with the two diﬀerent serum and
presenting EDEN15 motif should bind EDEN-BP in
in vitro and in vivo assays.
Binding of recombinant EDEN-BP to the 3’ UTR of
identified target mRNAs
To determine whether the identiﬁed target mRNAs could
eﬀectively bind EDEN-BP, we performed EMSA analyses
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Figure 2. Overrepresentation of the EDEN15 motif in the 30UTR of
mRNAs complexed to EDEN-BP. (A) MEME analysis of 62 sequences
binding EDEN-BP in vitro identiﬁed 39 times a 15 nt motif (EDEN15)
in 37 sequences (out of 62). These 39 motifs were aligned and used to
generate the EDEN15 motif represented here as a sequence logo.
(B) Occurences of mRNAs bearing the EDEN15 motif at a given score
in the 30 UTR from identiﬁed target mRNAs and control datasets.
UTR_array corresponds to all the 30 UTR available for mRNAs
represented on the microarray. UTR_target corresponds to all the 30
UTR available for the identiﬁed EDEN-BP target mRNAs.
UTR_target_Rev corresponds to the reverse complement of
the UTR_target dataset. UTR_Target_Shuﬄe corresponds to the
UTR_Target dataset after shuﬄing of the sequences.
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with recombinant EDEN-BP. We picked eight new
EDEN-BP targets for which the 30 UTR sequences could
be determined that were representatives of the range
of enrichment observed in our experiments and with
various predicted adenylation proﬁles (Figure 3A). We
also analyzed the previously identiﬁed target Eg1/Cdk2.
Using the EDEN15 motif we localized the potential
EDEN-BP binding site in these mRNAs 30 UTRs; the
match score for the identiﬁed motif ranged from 67 to
90% of the maximum match score. Selected portions of
candidates 30 UTRs centered on the EDEN15 motifs were
ampliﬁed by RT-PCR with the incorporation of a T7
promoter. Radiolabeled RNAs (<200-nt long) from these
templates were incubated with recombinant EDEN-BP
and complex formation was analyzed by native poly-
acrylamide gel electrophoresis. As shown on Figure 3B
(left panel) two complexes (denoted C1 and C2) were
sequentially formed when increasing concentrations of
EDEN-BP were added to the incubation mix. The two
complexes are compatible with the multimerization of
EDEN-BP on its target that has already been reported
(23). When the same experiment is conducted with
30 Eg5C6 (Figure 3B, right panel), a mutated EDEN
where a 6 nt substitution in the UGU motifs makes it
unable to bind EDEN-BP in UV-crosslinking assay (3),
complex C1 is formed but only at higher concentration of
recombinant protein and complex C2 is only detectable at
the maximum concentration of recombinant protein used
(1.25 mM). For all the EDEN-BP target tested, the aﬃnity
of EDEN-BP for the RNAs was estimated from the
concentration of protein that bound 50% of the RNA
probe. Because more than one complex could form on the
RNAs this value represents a good indication of the
binding aﬃnity for EDEN-BP and is termed here
apparent Kd. Average values from three diﬀerent experi-
ments and for the 10 RNA tested are presented on
Figure 3C. As already reported, the mutated version of the
Eg5-binding site (30 Eg5C6) has an apparent Kd value of
700 nM, corresponding to a very low aﬃnity binding sites.
Contrariwise, for all of the new target mRNAs, the
portions of the 30 UTR that contained a match for the
EDEN15 motif were shifted by recombinant EDEN-BP
with apparent Kd below 100 nM indicative of their ability
to eﬃciently bind the recombinant EDEN-BP. These
values are similar to the reported apparent Kd of CUG-
BP1 for Eg5 that is 34 nM (19).
In vivo binding to EDEN-BP
To determine whether the identiﬁed mRNAs were able to
bind in vivo to EDEN-BP we used UV-induced cross-
linking to evaluate the association of portion of the 30
UTR sequences with the endogenous EDEN-BP in UFE
extract. As can be observed on Figure 4A, all the tested
sequences from our screen present a radioactive signal at a
size compatible with EDEN-BP (Figure 4A, arrowhead).
This radiolabeled protein migrates at the same position
as the one for Aurora A(Eg2) and c-Mos RNA, two
known EDEN targets. B4, a RNA that is not bound to
EDEN-BP (9) does not present this signal.
To control the identity and speciﬁcity of the
observed binding, unlabeled EDEN-BP-speciﬁc (30 Eg5)
or non-speciﬁc (30 Eg5C6) RNAs were used as competitors
on a subset of sequences. The Eg5 sequence (30 Eg5)
bound a unique protein (Figure 4B, arrowhead) that could
be eﬃciently competed by a 10-fold excess of cold-speciﬁc
competitor (S10) but not by a 100-fold excess of non-
speciﬁc-cold competitor (NS100) (Figure 4B). No EDEN-
BP signal was observed for the radiolabeled 30 Eg5C6
RNA. For all the new target RNA tested, the EDEN-BP
signal (arrowhead) was eﬃciently competed by a 10-fold
excess of EDEN-BP-speciﬁc competitor and totally
competed by a 100-fold excess of EDEN-BP-speciﬁc
cold competitor, while very poorly by a 100-fold excess
of the non-speciﬁc competitor. These experiments
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Figure 3. EMSA for eight new EDEN-BP target mRNAs. (A) Based on
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conﬁrmed, therefore, that the identiﬁed mRNAs contain
a motif able to speciﬁcally bind EDEN-BP. Interestingly,
when cold-speciﬁc competitor is added one can observe
the enhancement of a radioactive signal migrating slightly
above EDENBP for some RNA (Lmo4, Cdk2, CPEB and
ZMPste 24). This suggests that competitive binding
between EDEN-BP and another RNA-BP may occur on
these RNA.
These results show that the tested RNAs bind both
recombinant and endogenous EDEN-BP. Therefore, the
combination of EDEN-BP IP and localization of the
EDEN-binding site with the deﬁned EDEN15 motif has
enabled us to identify new binding targets for EDEN-BP.
Cdk1 is deadenylated byanEDEN-BP-dependentmechanism
Among the RNA identiﬁed as target for EDENBP, Cdk1
was reported earlier to be translationally silent after
fertilization (26,27); therefore, we cloned the entire 30
UTR of X. tropicalis Cdk1 (ENSXETG00000003123) and
analyzed its adenylation behavior after injection into
X. laevis embryos. As can be observed in Figure 5A, 2 h
after injection, both the reporter with the Cdk1 30 UTR
(ORF-Cdk1) and the reporter with the Aurora A 30 UTR
region (ORF-AurA) have accumulated as deadenylated
mRNAs. It is clear that Cdk1 30 UTR targets a reporter
RNA for rapid deadenylation with kinetics similar to
those observed for Aurora A, a known target of EDEN-
BP-dependent deadenylation. It was previously showed
that coinjection of aE2 antibodies speciﬁcally inhibited
EDEN-BP-dependent deadenylation on a reporter RNA
containing an EDEN sequence (5,28). Therefore, to verify
that the 30 UTR of Cdk1 was targeting the mRNA for
EDEN-BP-dependent deadenylation, we coinjected the
ORF-Cdk1 reporter RNA with either puriﬁed antiEDEN-
BP antibodies (aE2) or control IgG. While ORF-Cdk1 is
deadenylated by 2 h postinjection in presence of control
IgG, the immunoneutralization of EDEN-BP led to a
complete inhibition of deadenylation with no accumula-
tion of poly(A) reporter RNA by 4 h postinjection. These
experiments clearly demonstrate that Cdk1 mRNA, that is
among the newly identiﬁed binding target for EDEN-BP,
is speciﬁcally deadenylated by an EDEN-BP-dependent
mechanism.
DISCUSSION
In the present work, we have identiﬁed 158 maternal
mRNAs that are new binding targets for EDEN-BP
(5% of the tested RNAs on the microarray); ﬁve mRNAs
are the previously identiﬁed EDEN-BP targets c-Mos,
Cdk2(Eg1), Aurora A(Eg2), Eg5/KLP and XSU(H), and
153 are newly identiﬁed target. Among the newly
identiﬁed target, xLMO4, a maternally expressed
member of the LIM-domain-only protein family was
independently shown to bind CUG-BP1/EDEN-BP in
mice (24). Interestingly, when we analyzed the X. tropicalis
LMO4 30 UTR that is highly conserved with the human
LMO4 30 UTR, the EDEN15 motif could be detected with
a best match score of 90%. This suggests that the binding
of CUG-BP1/EDENBP to LMO4 30 UTR is conserved
from Xenopus to human. Furthermore, we showed that a
small region of xtLMO4 was bound to CUG-BP1 both
in vitro (Figure 3) and in vivo (Figure 4B). This region
corresponds to the region independently identiﬁed as
binding CUG-BP1/EDEN-BP in mice (24).
Among the mRNAs copuriﬁed with EDEN-BP, those
encoding proteins involved in cell cycle control or oocyte
maturation are common when compared with the
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functional categories of the gene products represented on
the array; in particular, Aurora A(Eg2), Aurora B, CPEB,
c-Mos, Cdk1, Cdk2(Eg1), casein Kinase 2 beta, Bub 3,
Wee1, MELK(Eg3), Eg5/KLP and NEK2B are among the
mRNAs recovered in our screen. Interestingly, an analysis
of the expression proﬁles of these mRNAs, based on
EST representation, indicated that the majority of these
mRNAs (Aurora A(Eg2), Aurora B, CPEB, c-Mos,
Cdk2(Eg1), Bub 3, Wee1A, MELK(Eg3), Eg5/KLP and
NEK2B) are mainly restricted to the germline and
expression levels are usually low throughout development.
This could indicate that binding of EDEN-BP to these
mRNAs contribute to their low expression levels after
fertilization. For example, CPEB protein is degraded
during oocyte maturation with only 25% of the
protein present in stage VI oocytes remaining after
maturation (29). Destruction of CPEB is required for
meiotic progression and expression of a stable form of
CPEB in embryos blocks cell divisions (30). Another
intriguing observation comes from the simultaneous
presence of EDEN motifs in both Cdk1 and Cdk2. The
amount of the proteins encoded by these mRNAs
increases during oocyte maturation and then remain
constant after fertilization and until the MBT while their
mRNAs are not translated as observed by S35 labeling
(26,27). During the cleavage stage, Cdk2 is apparently in
limiting amount compared with cyclin E levels until the
MBT (27,31). Hence, the presence of the EDEN motif
in the Cdk2 30 UTR would reduce the translation of
this mRNA and, therefore, assist or even cause the
maintenance of the balance between Cdk2 and cyclin E.
Here, we demonstrated that Cdk1 30 UTR is a new
binding target for EDEN-BP and that EDEN-BP activity
is required for the rapid deadenylation driven by the Cdk1
30 UTR. It is therefore likely that EDEN-BP acts as a
translational repressor on both Cdk1 and Cdk2. As Ueno
and Sagata (32) presented evidence that, in the case of
c-Mos, the ability of EDEN to trigger translational
silencing and deadenylation was potentiated by
AUUUA tetranucleotides, it must be noted that the
Cdk1 30 UTR is devoid of any AUUUA but contain some
AU element located 30 of the EDEN. These observations
reinforce the hypothesis that the presence of an EDEN
motif may be part of a mechanism to ensure a limited
expression of some important cell cycle regulators in the
cleavage stage embryos. EDEN-BP protein is maternally
expressed but is activated only after fertilization (13). This
particularity may ensure that mRNAs containing EDEN
motifs are translationally repressed either to inhibit the
overaccumulation of stable protein encoded by maternal
mRNAs and required for early development, or to ensure
reduced expression of proteins that are unstable and
mainly required during oocyte maturation (such as c-Mos
or CPEB).
This does not mean that all the mRNAs identiﬁed
are rapidly deadenylated after fertilization. Post-
transcriptional processes are the results of a complex
interplay between RNA-BP with diﬀerent aﬃnity and
diﬀerent activity. Notably some of the newly identiﬁed
binding targets, such as xFRL1, are actually polyadeny-
lated after fertilization and their encoded protein
accumulates only after fertilization [(33,34), Figure 3 and
data not shown]. Whether EDEN-BP is implicated in this
polyadenylation possibly by associating with diﬀerent
partners or other sequences specify the postfertilization
polyadenylation of xFRL1 requires further study.
The SELEX information used to build a model for the
EDEN motif is coroborated by the enrichment of this
motif in the population of mRNA coimmunoprecipitated
with antiEDEN-BP antibodies. Furthermore, earlier
experiments [(35) and data not shown] indicated that
while a synthetic (UGUA)4 RNA was able to eﬃciently
crosslink EDEN-BP in Xenopus extracts, an (UAUG)4
motif was not. As deﬁned by the scoring matrix, the best
score for the (UGUA)4 motif is 84% (420/495) while it
is only 63% (313/495) for the (UAUG)4. Interestingly,
it was recently reported that Maskin and Cyclin B1 30
UTR bind EDEN-BP in X. laevis oocytes (36). We found
that the EDEN15 motif was present in the 30 UTR of
these mRNAs (Cyclin B1 (NM_001088495), Maskin
(NM_001088495) with a match score of 74 and 83%,
respectively.
The EDEN15 motif with a score of at least 70% is
found in the 30 UTR of >90% the coimmunoprecipitated
RNA. When a subset of the newly identiﬁed targets was
analyzed for in vivo and in vitro binding to EDEN-BP, the
localization of the EDEN motif was realized solely on
the base of the best EDEN15 motif in the 30 UTR and all
the tested RNA were eﬀectively associated to EDEN-BP
in our assays. Alternatively, and as has been shown for
CUG-BP1, binding sites may be located not only in the
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Figure 5. Cdk1 30 UTR target a reporter mRNA for EDEN-BP-
dependent deadenylation in Xenopus embryos. (A) The indicated
capped poly(A)+ and radiolabeled mRNAs (ORF-Cdk1, ORF-AurA)
were injected into two-cell embryos and samples were harvested at the
indicated time after injection (hpi). Total RNA were extracted and
separated by denaturing polyacrylamide gel electrophoresis.
Radiolabeled RNAs were revealed by Phosphorimaging. For ORF-
Cdk1, one can observe a small smiling of the gel. (B) ORF-Cdk1
mRNA was coinjected with either aE2 (antiEDEN-BP) antibody or
control IgG as indicated. Samples were harvested at the indicated time
after injection. Radiolabeled RNAs were analyzed as described for A).
RNA size markers are positioned on the left side of the panel. The
asterisk () denote the position of the poly(A) mRNAs.
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30 UTR (28) but also in the introns (37), or the 50 UTR
(38). It is therefore possible that some mRNAs are
actually associated to EDEN-BP by intronic sites.
However, this is very unlikely in the context of this
study as there is no ongoing transcription at the stages
studied and therefore no pre-mRNA should be present. It
is also possible that EDEN-BP is associated to mRNA by
sites located in the 50 UTR, but this region being poorly
annotated, the analysis of the 50 UTR is restricted to a
very small number of sequences.
Some mRNAs may be enriched in the immunoprecipi-
tated pool due to their association in a RNP complex
containing EDEN-BP and other RNA-BPs that speciﬁ-
cally bind to the RNA so that the contribution of EDEN
binding motif is only weak or even absent. Such a
situation has already been described for the mRNAs
that bind both Pumilio-2 (Pum-2) and deleted in
azoospermia-like (DAZL) (39). However, as the tested
RNAs bind EDEN-BP both in vitro and in vivo, we think
that this will be a minor contribution to the pool of 158
maternal mRNAs selected with both antibodies.
We have identiﬁed 158 mRNAs as binding targets for
the endogenous EDEN-BP protein. The identiﬁed
mRNAs contain proportionally more potential EDEN
motifs in their 30 UTR than the currently available
X. tropicalis 30 UTRs analyzed as a whole. EMSA
experiments with recombinant EDEN-BP and UV-
crosslinking experiments with egg extract indicates that
all the tested (12) potential EDEN containing RNAs can
bind endogenous EDEN-BP. We have therefore identiﬁed
on a large-scale targets for a RNA-BP known for its
role in controlling speciﬁcally mRNA translation.
Furthermore, we demonstrated that Cdk1 30 UTR, one
of the newly identiﬁed target is rapidly and speciﬁcally
deadenylated by and EDEN-BP-dependent mechanism.
It would be of interest to determine to what extent the
binding of EDEN-BP controls the translation of the newly
identiﬁed targets by comparing large-scale polysomal
analyses in native conditions and when EDEN-BP is
knocked down.
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